S

Sanofi

Global pharma company; vaccines and R&D

Health, Safety and Environment Manager

Full-TimeUpdated on 10/23/2026Deadline 10/31/26
No salary listed
Expert
Bachelor's
Hyderabad, Telangana, India
In Person
Facilities OperationsEnvironmental Health & Safety

About the job

Requirements
  • 10 to 15 years of experience in Corporate HSE, handling large sites in a Corporate Function.
  • Demonstrated integrity and responsibility.
  • Strong communication and interpersonal abilities.
  • Service orientation, high emotional intelligence, and empathy.
  • Ability to work autonomously in ambiguous environments and manage through influence.
  • Cultural awareness across regions of India.
  • Proactive, agile approach and readiness to go the extra mile during challenges and uncertainty.
  • Creative solutioning skills and an open-minded approach across multiple disciplines.
  • Ability to coach and mentor team members, including partners.
  • Adaptability, multitasking, organizational skills, and willingness to learn.
  • Risk assessment and management skills to identify, evaluate, and mitigate risks.
  • Regulatory compliance skills for the Hub and its operations.
  • Incident investigation skills for incidents, accidents, and near misses.
  • Ability to conduct HSE audits and develop mitigation plans.
  • Ability to develop and maintain emergency response plans.
  • Environmental management skills to implement environmental sustainability practices.
  • Ability to develop HSE management systems, including ISO 45001 and ISO 14001.
  • Ability to create and deliver HSE training programs.
  • Ability to analyze and report HSE performance data.
  • Minimum of a Diploma in Industrial Safety, Fire Safety Engineering, or NEBOSH International Diploma.
  • Proficiency in spoken and written English and Hindi.
Responsibilities
  • Lead implementation of the HSE program, collaborating with senior management, line management, and residents to implement a proactive Health Management System that complies with local regulations and Sanofi HSE requirements.
  • Implement the HSE management system, monitor ongoing HSE construction, expansion and MAC projects, deploy HSE cultural excellence initiatives, analyze hazardous situations, and measure strategies and programs for continuous improvement.
  • Coordinate with HSE country, regional, and global teams on HSE leadership and governance, workplace safety, road safety, health promotion, environment and sustainability projects, audit support, training and development, crisis management, and wellness programs.
  • Lead strategic HSE priorities with Hospitality Management, maintaining alignment with the Global HSE Policy and framework.
  • Identify, analyze, and mitigate HSE risks; ensure compliance with regulatory and Sanofi HSE requirements; and improve HSE performance by reducing accidents, incidents, chronic effects, waste, and emissions while conserving natural resources.
  • Implement road safety programs and monitor progress.
  • Lead sustainability program implementation in the Hub.
  • Align site and country HSE strategies with Global Operations objectives, Group standards, and corporate policies; lead and support global, regional, and local HSE initiatives, priorities, and governance programs.
  • Establish, chair, and govern the HSE Committee and cross-functional forums; oversee annual planning, agendas, action tracking, and timely closure for health, wellness, and sustainability mandates across the Hub.
  • Conduct periodic HSE performance reviews, including regulatory compliance gap analyses, standards implementation assessments, KPI tracking, and follow-up on corrective and preventive action plans arising from internal and external HSE audits.
  • Partner with business functions, workplace experience teams, and external service partners to strengthen safety culture, workforce well-being, and operational sustainability.
  • Architect, deploy, and maintain an integrated HSE Management System across Hub operations, ensuring governance, statutory compliance, and continuous performance improvement.
  • Conduct risk assessments for routine workplace operations, facility expansion projects, high-risk work environments, and internal and external events, applying hierarchy-of-control measures.
  • Direct the Contractor Safety Management program and oversee the Permit-to-Work system, including on-site verification, pre-qualification standards, and compliance with safe operating procedures for routine services and capital expansion projects.
  • Oversee hazardous substance protocols, process safety assessments, chemical handling standards, and storage containment measures across site operations.
  • Implement and monitor leading safety rituals, including Plan vs. Actual tracking, and operationalize regular Project Safety Reviews for capital works.
  • Supervise daily operations, clinical governance, and service-level delivery of the on-site Occupational Health Center, ensuring medical confidentiality, occupational hygiene standards, and regulatory compliance.
  • Lead health promotion and well-being programs, including All Well initiatives; organize employee engagement campaigns such as One Hour Stop for Safety, Environmental Days, and targeted wellness interventions.
  • Develop, maintain, and test site-specific Emergency Management and Crisis Response Plans for local industrial hazards, severe weather, and business continuity vulnerabilities; provide incident command during major emergencies, critical injuries, or environmental releases, and lead post-event recovery and forensic event reviews.
  • Formulate and execute a multi-year HSE and Sustainability Action Plan aligned with Global Group commitments, embedding environmental targets in Hub operations.
  • Partner with workplace experience and Facilities teams on sustainability reporting, energy conservation and energy sobriety, waste reduction and diversion, and circular recycling workflows.
  • Design and roll out green communications to encourage campus residents to participate in energy conservation, waste segregation, and carbon-reduction initiatives.
  • Direct incident reporting, lead investigations of near-misses, injuries, and operational deviations, and conduct root-cause analysis and corrective and preventive action lifecycle tracking using enterprise tools such as QualiPSO.
  • Administer and maintain site operations on global and local digital platforms, including QualiPSO, SHERPA, and the HSE Index Portal.
  • Build and manage automated management information system dashboards and workflows using Microsoft Power Apps and Power BI to provide real-time HSE performance analytics.
  • Consolidate, validate, and report monthly, quarterly, and annual safety, occupational health, and sustainability metrics for Hub leadership, regional stakeholders, and statutory bodies.
  • Develop an annual Hub HSE training matrix and training calendar across functional departments for statutory compliance and operational excellence.
  • Design, author, and deliver HSE training modules, interactive e-learning sessions, and targeted toolkits covering contractor safety, workplace ergonomics, chemical safety, and road safety.
Desired Qualifications
  • Experience with WELL Building and Green Building certifications.
  • Proficiency in other regional dialects.

About the company

Sanofi is a global pharmaceutical and biotechnology company that develops, manufactures, and sells prescription medicines, over-the-counter products, and vaccines. Its products span immunology, oncology, rare diseases, and vaccines, addressing unmet medical needs through a strong focus on research and development. Sanofi's core product model relies on large-scale R&D, strategic partnerships, and licensing to bring new therapies to markets, with revenue generated from product sales and collaborations. The company differentiates itself by leveraging its global reach, diverse portfolio, and emphasis on patient-centric solutions, safety, and quality to navigate regulatory environments in developed and emerging markets. The company’s goal is to improve health outcomes and quality of life for people worldwide by delivering innovative treatments and vaccines that meet unmet medical needs.

Company Size

10,001+

Company Stage

IPO

Headquarters

Paris, France

Founded

1973

Get referred to Sanofi

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • July 10, 2026 FDA approval of Sarclisa Escena created the first on-body cancer injector.
  • June 13, 2026 FDA accelerated approval expanded Tzield into recently diagnosed stage 3 T1D.
  • Q2 2026 sales grew 17.8% at CER, with Dupixent and Beyfortus leading.

What critics are saying

  • Texas sued Sanofi on February 19, 2026 over provider bribery and Medicaid fraud.
  • Sanofi sued Pfizer and Moderna on July 15, 2026, extending costly mRNA patent warfare.
  • Dupixent concentration makes 2030s patent loss an existential revenue shock.

What makes Sanofi unique

  • Dupixent reached €5.2 billion quarterly sales in Q2 2026 across nine indications.
  • October 1, 2026, Sanofi and Regeneron added four long-acting antibodies to their Alliance.
  • Sanofi's 61-project pipeline spans immunology, rare diseases, vaccines, neurology, and oncology.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Professional Development Budget
  • Parental Leave

Company News

Associated Press
Oct 19th, 2026
Enable Injections wins first Japan approval for enFuse on-body injector via Sanofi's CirCLIQ

Enable Injections has won its first commercial product approval in Japan. The country's Ministry of Health, Labour and Welfare approved the company's enFuse On-Body Delivery System through Sanofi's CirCLIQ Injector. The device delivers a subcutaneous form of Sarclisa (isatuximab) with the push of a button, for treating multiple myeloma. It is the first anticancer treatment given through an on-body injector in Japan. The approval follows recent clearances in the US and Europe. Japan approved Sarclisa SC in June 2026, backed by the IRAKLIA phase 3 study, which showed the subcutaneous form was non-inferior to intravenous delivery. "We're proud to partner with Sanofi to bring our enFuse technology to patients in Japan," said Michael D. Hooven, chairman and chief executive officer of Enable.

Yahoo Finance
Oct 1st, 2026
Sanofi, Regeneron expand alliance in up to $8B deal for immunology drugs

France's Sanofi and US-based Regeneron Pharmaceuticals will expand their 20-year partnership to jointly develop and market immunology medicines in a deal worth up to $8 billion. Regeneron will receive $1 billion upfront, with potential additional payments of up to $7 billion tied to development, regulatory, and commercial targets. The collaboration will add four next-generation immunology drug candidates invented by Regeneron, with one currently in early-stage trials for eczema. The companies will equally share development costs and future profits from new drugs, whilst their existing profit-sharing agreement for top-selling medicine Dupixent remains unchanged. The deal settles prior litigation between the companies and marks an early move by Sanofi's new chief executive Belen Garijo to strengthen the company's pipeline.

Sanofi
Sep 20th, 2026
Press Release: Sanofi completes acquisition of Vicebio

Sanofi completes acquisition of Vicebio Paris, December 4, 2025. Sanofi announces the completion of its acquisition of Vicebio Ltd (“Vicebio”). This acquisition brings an early-stage combination...

Sanofi
Sep 20th, 2026
Press Release: Sanofi completes acquisition of Blueprint Medicines

Sanofi completes acquisition of Blueprint Medicines Paris, July 18, 2025. Sanofi today announces the completion of its acquisition of Blueprint Medicines Corporation (Blueprint), adding to its...

Sanofi
Sep 20th, 2026
Press Release: Sanofi completes the acquisition of Dynavax

Sanofi completes the acquisition of Dynavax Paris, February 10, 2026. Sanofi today announced that it has completed the acquisition of Dynavax Technologies Corporation (Dynavax). The acquisition...